PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19210527-0	2009	Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation.	Glucose	33-40	calcineurin binding protein 1	Homo sapiens	0-21	
28041666-1	2017	OBJECTIVE: To investigate the role of calcineurin inhibitor exposure and states of insulin resistance-obesity and adolescence-in prediabetes after pediatric liver transplant via oral glucose tolerance testing, which previously has not been done systematically in these at-risk youths.	Glucose	183-190	calcineurin binding protein 1	Homo sapiens	38-59	
15237243-9	2004	A Cox proportional hazards model adjusting for baseline covariates including age, gender, race, type of transplant, delayed graft function, baseline blood pressure and random serum glucose and cholesterol demonstrated that only calcineurin inhibitor dose reduction but not withdrawal, older age, delayed graft function, higher serum creatinine at the time of intervention, and higher diastolic blood pressure and serum glucose, correlated with graft loss.	Glucose	181-188	calcineurin binding protein 1	Homo sapiens	228-249	
15237243-9	2004	A Cox proportional hazards model adjusting for baseline covariates including age, gender, race, type of transplant, delayed graft function, baseline blood pressure and random serum glucose and cholesterol demonstrated that only calcineurin inhibitor dose reduction but not withdrawal, older age, delayed graft function, higher serum creatinine at the time of intervention, and higher diastolic blood pressure and serum glucose, correlated with graft loss.	Glucose	419-426	calcineurin binding protein 1	Homo sapiens	228-249